The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism

New England Journal of Medicine

Volumn 338, Issue 17, 1998, Pages 1169-1173

  Sørensen, Henrik Toft ^a,b   Mellemkjær, Lene ^c   Steffensen, Flemming Hald ^a   Olsen, Jørgen H ^c   Nielsen, Gunnar Lauge ^d  

^a UNIVERSITY OF AARHUS   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; LIVER CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL;

AGED; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; PULMONARY EMBOLISM; RISK FACTORS; THROMBOPHLEBITIS;

EID: 0032559947     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199804233381701     Document Type: Article

References (18)

1. Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ. Cancer and venous thromboembolism. Am Heart J 1996;132:850-5.
2. Plegmasia alba dolens. In: Trousseau A. Lectures on clinical medicine, delivered at the Hotel-Dieu, Paris. Cormack JR, trans. London: New Sydenham Society, 1872:281-95.
3. Monreal M, Lafoz E, Casals A, et al. Occult cancer in patients with deep venous thrombosis: a systematic approach. Cancer 1991;67:541-5.
4. Goldberg RJ, Seneff M, Gore JM, et al. Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med 1987;147:251-3.
5. Nordström M, Lindblad B, Anderson H, Bergqvist D, Kjellström T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 1994;308:891-4.
6. Prandoni P, Lensing AWA, Büller HR, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992;327: 1128-33.
7. Cornuz J, Pearson SD, Creager MA, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Intern Med 1996;125:785-93.
8. O'Connor NT, Cederholm-Williams SA, Fletcher EW, Allington M, Sharp AA. Significance of idiopathic deep venous thrombosis. Postgrad Med J 1984;60:275-7.
9. Griffin MR, Stanson AW, Brown ML, et al. Deep vein thrombosis and pulmonary embolism: risk of subsequent malignant neoplasms. Arch Intern Med 1987;147:1907-11.
10. Sundhedsstyrelsen. Aktiviteten i sygehusvaesenet 1979. Copenhagen, Denmark: Sygehusstatistik, 1981.
11. Klassifikation af sygdomme. Copenhagen, Denmark: Sundhedsstyrelsen, 1976.
12. Storm HH, Pihl J, Michelsen E, Nielsen AL, eds. Cancer incidence in Denmark 1993. Copenhagen, Denmark: Danish Cancer Society, 1996.
13. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997;44:535-9.
14. Rothman KJ, Boice JD. Epidemiologic analyses with a programmable calculator. Washington, D.C.: Government Printing Office, 1979. (DHHS publication no. (NIH) 79-1649.)
15. Sorensen HT. Regional administrative health registries as a resource in clinical epidemiology. Int J Risk Saf Med 1997;10:1-22.
16. Prins MH, Lensing AW, Hirsh J. Idiopathic deep venous thrombosis: is a search for malignant disease justified? Arch Intern Med 1994;154: 1310-2.
17. Naschitz JE, Yeshurun D, Eldar S, Lev LM. Diagnosis of cancer-associated vascular disorders. Cancer 1996;77:1759-67.
18. Levine M, Hirsh J. The diagnosis and treatment of thrombosis in the cancer patient. Semin Oncol 1990;17:160-71.